Blog

Elad Sharon: Honored to receive a plaque for our team’s work getting the first immune checkpoint inhibitor approved in sarcoma!

Photo of Elad Sharon from American Association for Cancer Research

Feb 23, 2024, 17:26

Elad Sharon: Honored to receive a plaque for our team’s work getting the first immune checkpoint inhibitor approved in sarcoma!

Elad Sharon, Medical Oncologist at Dana-Farber Cancer Institute, made the following post on X:

“Honored to receive a plaque for our team’s work getting the first immune checkpoint inhibitor approved in sarcoma! Alveolar Soft Part Sarcoma is a rare cancer! Thanks for this NIH Director’s award! My last for work I did NCI CTEP Clinical Research! Thanks to National Institutes of Health, Genentech & FDA Oncology.”

Source: Elad Sharon/X

Alveolar Soft Part Sarcoma cancer Elad Sharon FDA Oncology Genentech immune checkpoint inhibitor National Institutes of Health NCI CTEP Clinical Research NIH NIH Director OncoDaily Oncology Research sarcoma

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Isabel Mestres: In a world where the fight against cancer knows no borders, collaboration is not optional - it’s essential

Special Coverage